Inovio Pharmaceuticals Inc

INO

Company Profile

  • Business description

    Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

  • Contact

    660 West Germantown Pike
    Suite 110
    Plymouth MeetingPA19462
    USA

    T: +1 267 440-4200

    E: [email protected]

    https://www.inovio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    134

Inovio Pharmaceuticals Inc News & Analysis

stocks

Looking under the hood at Robinhood

We review some of the platform's most popular stocks onĀ 11 different measures of equity-related risk.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,999.90109.101.23%
CAC 407,822.0099.911.29%
DAX 4024,370.93361.551.51%
Dow JONES (US)44,484.49229.710.52%
FTSE 1008,972.6446.090.52%
HKSE24,643.88144.930.59%
NASDAQ20,885.65155.160.75%
Nikkei 22539,787.34113.85-0.29%
NZX 50 Index12,877.0928.32-0.22%
S&P 5006,297.3633.660.54%
S&P/ASX 2008,751.20112.201.30%
SSE Composite Index3,528.9012.070.34%

Market Movers